Socioeconomic factors and SGLT2 inhibitor initiation in patients with heart failure—a claims data analysis - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of Socioeconomic Status on the Initiation of SGLT2 Inhibitors in Heart Failure Patients: An Analysis of Claims Data

  • By

  • Lisa–Marie Müller

  • Jonas Krampe

  • Julius L. Katzmann

  • Ulrich Laufs

  • Alexander Kogel

  • July 7, 2026

Share

  • 1

    Socioeconomic factors influence the risk of heart failure and cardiovascular outcomes, impacting treatment access and quality.

  • 2

    SGLT2 inhibitors are recommended for all heart failure patients, improving outcomes in those with reduced and preserved ejection fraction.

  • 3

    Previous studies indicate that low socioeconomic status correlates with lower prescription rates of guideline-directed therapies.

  • 4

    This study aims to analyze real-world prescription patterns of SGLT2 inhibitors, focusing on socioeconomic factors affecting initiation.

  • 5

    Data from the German Analysis Database and INKAR database will be utilized to assess patient and area-level factors influencing SGLT2i access.

Original Source(s)

Related Content